The prognostic value of expression of HIF1α, EGFR and VEGF-A, in localized prostate cancer for intermediate- and high-risk patients treated with radiation therapy with or without androgen deprivation therapy
about
Mechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate CancerGenomic and Histopathological Tissue Biomarkers That Predict Radiotherapy Response in Localised Prostate CancerMembrane carbonic anhydrase IX expression and relapse risk in resected stage I-II non-small-cell lung cancerPrognostic role of vascular endothelial growth factor in prostate cancer: a systematic review and meta-analysis.Biological effects of novel "combi-targeting" molecule and its effect on DNA repair pathway in hormone-refractory prostate cancerGenetic polymorphisms in key hypoxia-regulated downstream molecules and phenotypic correlation in prostate cancer.VEGF is associated with the poor survival of patients with prostate cancer: a meta-analysis.Quantitative [18F]FMISO PET Imaging Shows Reduction of Hypoxia Following Trastuzumab in a Murine Model of HER2+ Breast Cancer.The osteoblastic and osteoclastic interactions in spinal metastases secondary to prostate cancer.Gαs protein expression is an independent predictor of recurrence in prostate cancerCell mates: paracrine and stromal targets for prostate cancer therapy.An arranged marriage for precision medicine: hypoxia and genomic assays in localized prostate cancer radiotherapy.Molecular markers for prostate cancer in formalin-fixed paraffin-embedded tissues.Pathogenic Role of Exosomes in Epstein-Barr Virus (EBV)-Associated Cancers.TGF-β2 initiates autophagy via Smad and non-Smad pathway to promote glioma cells' invasion.Mutation status of somatic EGFR and KRAS genes in Chinese patients with prostate cancer (PCa).Fatty Acids and Calcium Regulation in Prostate Cancer.Notch1 serves as a prognostic factor and regulates metastasis via regulating EGFR expression in hypopharyngeal squamous cell carcinoma
P2860
Q26766638-8751C2C2-F587-4CF6-B7D0-935C66D02C67Q26778586-A9F91348-47D7-4B77-8780-B1537904E2C0Q33856008-99B8D336-1984-471C-81E4-8E08148424B9Q35480244-BCFAE893-FE74-4EAE-8EA1-8EBA98BA9FE9Q36057101-1D7AFB8A-050B-41B2-A245-5CCDF831B50DQ36265638-4809C3D3-3067-4CE8-8CA5-F41EE4F4EBAFQ36450743-86B5720D-C8C6-4508-A2C9-D89B7D5AC58FQ37559704-D31D6FF9-4538-4C3D-8A34-4301E9DD006BQ37615017-1F784E2D-5713-4665-B1DB-F1DADF9B267CQ37706058-87B60208-3FCF-4D66-8AA2-4F079DCF6CE1Q38121792-6BD85657-E3FE-46C9-8B19-7644DA18EC0EQ38192714-ADAC486F-B418-4CCF-9C90-EAC0FB9EDBD6Q42184292-1AB30C52-BA4A-4565-8841-8E03321FF2ACQ45325266-56D5CD97-C457-42E7-AF0E-25B8233BDEBCQ45809932-90CDA989-0BD6-41A3-8499-6C32AE5B863DQ54373177-4EDCB658-88DA-4D8E-B403-BBD3CBFFAB43Q55468609-22D8F18D-42CA-4057-9224-6C90396BBE1AQ58698686-EB8B6F5A-7F11-4BCD-AE3B-53DA7164AAF6
P2860
The prognostic value of expression of HIF1α, EGFR and VEGF-A, in localized prostate cancer for intermediate- and high-risk patients treated with radiation therapy with or without androgen deprivation therapy
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The prognostic value of expres ...... t androgen deprivation therapy
@en
type
label
The prognostic value of expres ...... t androgen deprivation therapy
@en
prefLabel
The prognostic value of expres ...... t androgen deprivation therapy
@en
P2093
P2860
P356
P1433
P1476
The prognostic value of expres ...... t androgen deprivation therapy
@en
P2093
Christophe Combescure
Damien C Weber
Jean-Christophe Tille
Jean-François Egger
Karim Hammad
Laura Rubbia-Brandt
Mahomet Laouiti
Perrine Granger
Raymond Miralbell
P2860
P2888
P356
10.1186/1748-717X-7-66
P577
2012-04-30T00:00:00Z
P6179
1029590324